Inverse Relationship of Bone Mineral Density and Serum Level of N-terminal Pro-B-type Natriuretic Peptide in Peritoneal Dialysis Patients

Overview

Journal Tzu Chi Med J

Specialty General Medicine

Date 2017 Aug 1

PMID 28757725

Citations 4

Authors

Chih-Hsien Wang

Jen-Pi Tsai

Yu-Hsien Lai

Yu-Li Lin

Chiu-Huang Kuo

Bang-Gee Hsu

Affiliations

Soon will be listed here.

Abstract

Objective: Chronic kidney disease is associated with decreased bone mineral density (BMD). In this study, the relationship between BMD and the fasting serum concentration of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) was evaluated in peritoneal dialysis (PD) patients.

Material And Methods: Fasting blood samples were obtained from 52 PD patients. BMD was measured by dual energy X-ray absorptiometry of the lumbar vertebrae (L2-L4). The serum NT-pro-BNP level was measured by an electrochemiluminescence immunoassay.

Results: Ten patients (19.2%) had osteoporosis, 23 patients (44.2%) had osteopenia, and 19 patients had normal BMD. Increased serum NT-pro-BNP ( < 0.001), advanced age ( = 0.012), decreased body mass index ( = 0.006), body height ( = 0.018), and body weight ( = 0.004) were associated with lower lumbar T-scores, but sex, menopausal status, PD modality, diabetes mellitus, and hypertension were not. Multivariate forward stepwise linear regression analysis with adjustment for age, body height, body weight, body mass index, and log-NT-pro-BNP indicated that a high serum level of log-NT-pro-BNP ( change = 0.346; < 0.001) and low body weight ( change = 0.208; < 0.001) were significantly and independently associated with poor lumbar BMD.

Conclusion: A high serum level of NT-pro-BNP and low body weight were associated with poor BMD in PD patients.

Citing Articles

Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).

Trudzinski F, Jorres R, Alter P, Watz H, Vogelmeier C, Kauczor H Respir Res. 2024; 25(1):274.

PMID: 39003487 PMC: 11245771. DOI: 10.1186/s12931-024-02902-2.

Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study.

Fang Y, Wang L, Xing W, Wu Q, Tong Q, Yu Y Eur Geriatr Med. 2021; 9(2):183-189.

PMID: 34654253 DOI: 10.1007/s41999-018-0027-5.

Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population.

Chen P, Yan P, Wan Q, Zhang Z, Xu Y, Miao Y BMC Musculoskelet Disord. 2021; 22(1):261.

PMID: 33691659 PMC: 7944612. DOI: 10.1186/s12891-021-04138-3.

High serum leptin level is associated with peripheral artery disease in adult peritoneal dialysis patients.

Lai Y, Wang C, Tsai J, Hou J, Lee C, Hsu B Tzu Chi Med J. 2018; 30(2):85-89.

PMID: 29875588 PMC: 5968748. DOI: 10.4103/tcmj.tcmj_8_18.

References

Sommerer C, Beimler J, Schwenger V, Heckele N, Katus H, Giannitsis E . Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007; 37(5):350-6. DOI: 10.1111/j.1365-2362.2007.01785.x. View

Reid I . Relationships between fat and bone. Osteoporos Int. 2007; 19(5):595-606. DOI: 10.1007/s00198-007-0492-z. View

Nishikimi T, Kuwahara K, Nakao K . Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol. 2011; 57(2):131-40. DOI: 10.1016/j.jjcc.2011.01.002. View

Jeong J, Lee H, Kim Y, Kim J, Kang S, Kim S . Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients. Clin Nephrol. 2010; 74(5):336-42. DOI: 10.5414/cnp74336. View

Loncar G, Fulster S, von Haehling S, Popovic V . Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure. Int J Cardiol. 2011; 162(2):77-85. DOI: 10.1016/j.ijcard.2011.09.079. View

Chen Y, Lee M, Lee C, Ho G, Yin W, Chang Y . N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients. J Atheroscler Thromb. 2013; 20(7):646-53. DOI: 10.5551/jat.17780. View

Gupta A, Huang M, Prasad G . Determinants of bone mineral density in stable kidney transplant recipients. J Nephrol. 2011; 25(3):373-83. DOI: 10.5301/jn.5000015. View

Jadoul M, Albert J, Akiba T, Akizawa T, Arab L, Bragg-Gresham J . Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006; 70(7):1358-66. DOI: 10.1038/sj.ki.5001754. View

Stein M, Packham D, Ebeling P, Wark J, Becker G . Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis. 1996; 28(4):515-22. DOI: 10.1016/s0272-6386(96)90461-8. View

10.

Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I . Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011; 96(9):2703-13. DOI: 10.1210/jc.2011-0047. View

11.

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K . Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 69(11):1945-53. DOI: 10.1038/sj.ki.5000414. View

12.

Yee-Moon Wang A . Clinical utility of natriuretic peptides in dialysis patients. Semin Dial. 2012; 25(3):326-33. DOI: 10.1111/j.1525-139X.2012.01079.x. View

13.

Ersoy F, Passadakis S, Tam P, Memmos E, Katopodis P, Ozener C . Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab. 2005; 24(1):79-86. DOI: 10.1007/s00774-005-0650-3. View

14.

Clerico A, Recchia F, Passino C, Emdin M . Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2005; 290(1):H17-29. DOI: 10.1152/ajpheart.00684.2005. View

15.

Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T . Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999; 33(2):287-93. DOI: 10.1016/s0272-6386(99)70302-1. View

16.

Ersoy F . Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol. 2006; 39(1):321-31. DOI: 10.1007/s11255-006-9109-2. View

17.

Gomez-Ambrosi J, Rodriguez A, Catalan V, Fruhbeck G . The bone-adipose axis in obesity and weight loss. Obes Surg. 2008; 18(9):1134-43. DOI: 10.1007/s11695-008-9548-1. View

18.

Sharma R, Gaze D, Pellerin D, Mehta R, Gregson H, Streather C . Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart. 2006; 92(10):1518-9. PMC: 1861028. DOI: 10.1136/hrt.2005.082313. View

19.

Gopal D, Iqbal M, Maisel A . Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med. 2011; 123(6):102-13. DOI: 10.3810/pgm.2011.11.2500. View

20.

Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S . Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res. 2008; 24(2):241-50. DOI: 10.1359/jbmr.081006. View